149 related articles for article (PubMed ID: 32980874)
1. ESC Advocacy (2018-2020): contributing to the ESC mission of reducing the burden of cardiovascular disease.
Badimon L
Cardiovasc Res; 2020 Oct; 116(12):e169-e170. PubMed ID: 32980874
[No Abstract] [Full Text] [Related]
2. The ESC Global Affairs Committee (2018-20): tackling cardiovascular disease worldwide.
Grobbee DE
Cardiovasc Res; 2020 Dec; 116(14):e212-e214. PubMed ID: 33245755
[No Abstract] [Full Text] [Related]
3. Work environment: An opportunity for ground-breaking collaborations in cardiovascular disease prevention.
Ferrario MM; Landsbergis P; Tsutsumi A; Li J; Hynek P; Krause N; Smith P; Holtermann A; Clays AE;
Eur J Prev Cardiol; 2017 May; 24(2_suppl):4-6. PubMed ID: 28440685
[No Abstract] [Full Text] [Related]
4. California ACC goals.
Bommer WJ
Rev Cardiovasc Med; 2012; 13(2-3):e121-3. PubMed ID: 23160160
[TBL] [Abstract][Full Text] [Related]
5. Patient engagement at the heart of all European Society of Cardiology activities.
Fitzsimons D
Cardiovasc Res; 2019 Aug; 115(10):e99-e101. PubMed ID: 31326979
[No Abstract] [Full Text] [Related]
6. Policymakers' perceptions of cardiovascular health in Europe.
Gyberg V; Rydén L
Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):745-53. PubMed ID: 21450603
[TBL] [Abstract][Full Text] [Related]
7. EUR-ASSESS Project Subgroup Report on Dissemination and Impact.
Granados A; Jonsson E; Banta HD; Bero L; Bonair A; Cochet C; Freemantle N; Grilli R; Grimshaw J; Harvey E; Levi R; Marshall D; Oxman A; Pasart L; Räisänen V; Rius E; Espinas JA
Int J Technol Assess Health Care; 1997; 13(2):220-86. PubMed ID: 9194353
[No Abstract] [Full Text] [Related]
8. BENEFIT for all: An ecosystem to facilitate sustained healthy living and reduce the burden of cardiovascular disease.
Keesman M; Janssen V; Kemps H; Hollander M; Reimer WSO; Gemert-Pijnen LV; Hoes A; Kraaij W; Chavannes N; Atsma D; Kraaijenhagen R; Evers A;
Eur J Prev Cardiol; 2019 Apr; 26(6):606-608. PubMed ID: 30486650
[No Abstract] [Full Text] [Related]
9. Let's Face It: Consumer-Focused Technology Is the Future of Cardiovascular Disease Prevention and Treatment.
Franklin NC; Pratt M
Prog Cardiovasc Dis; 2016; 58(6):577-8. PubMed ID: 27180944
[No Abstract] [Full Text] [Related]
10. Building on a foundation of strong clinical trial data, SCCT advocacy gaining momentum with U.S. payers and stakeholders: Advocacy updates over the past year.
Thomas DM; Shaw LJ
J Cardiovasc Comput Tomogr; 2018; 12(6):e24-e25. PubMed ID: 30322773
[No Abstract] [Full Text] [Related]
11. Constitution and By-Laws.
Trans Am Clin Climatol Assoc; 2015; 126():xlviii-xlvi. PubMed ID: 26330699
[No Abstract] [Full Text] [Related]
12. European Heart Rhythm Association Young Electrophysiology Community: introducing the National Ambassadors of Germany, Lebanon, and Croatia.
Kutyifa V; Duncker D; Refaat MM; Pavlovic N; Kosiuk J
Europace; 2019 Jan; 21(1):175-176. PubMed ID: 30169625
[No Abstract] [Full Text] [Related]
13. The European Heart Health Charter: towards a healthier Europe.
Rydén L; Martin J; Volqvartz S
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):355-6. PubMed ID: 17568232
[No Abstract] [Full Text] [Related]
14. PASCAR and WHF Cardiovascular Diseases Scorecard project.
Dzudie A; Fourie JM; Scholtz W; Scarlatescu O; Nel G; Kingue S
Cardiovasc J Afr; 2020; 31(2):103-110. PubMed ID: 33094797
[TBL] [Abstract][Full Text] [Related]
15. Charting Our Future Together: Turning Discovery Science Into Cardiovascular Health.
Gibbons GH
Circulation; 2017 Aug; 136(7):615-617. PubMed ID: 28808143
[No Abstract] [Full Text] [Related]
16. Clinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC.
Anderson JL; Antman EM; Harold JG; Jessup M; O'Gara PT; Pinto FJ; Vardas PE; Zamorano JL
Circulation; 2014 Dec; 130(24):2213-4. PubMed ID: 25085963
[No Abstract] [Full Text] [Related]
17. Familial hypercholesterolaemia patient support groups and advocacy: A multinational perspective.
Payne J; Williams S; Maxwell D; Pariente MT; Olivares RA; Janssen Ten Haaf M; Wong-Rieger D; Rieger F; Covato A; Wong-Rieger H; Cermakova L; Wilemon K
Atherosclerosis; 2018 Oct; 277():377-382. PubMed ID: 30270074
[TBL] [Abstract][Full Text] [Related]
18. Development of the roadmap for reducing cardiovascular morbidity and mortality through the detection, treatment and control of hypertension in Africa: report of a working group of the PASCAR Hypertension Task Force.
Dzudie A; Kane A; Kramoh E; Anzouan-Kacou JB; Damourou JM; Allawaye L; Nzisabira J; Mousse L; Balde D; Nouhom O; Nkoa JL; Kaki K; Djomou A; Menanga A; Nganou CN; Mipinda JB; Nebie L; Kuate LM; Kingue S; Ba SA;
Cardiovasc J Afr; 2016; 27(3):200-202. PubMed ID: 27841905
[TBL] [Abstract][Full Text] [Related]
19. The Turkish Society of Cardiology--towards the 50th anniversary: dedication to continuous progress in cardiovascular health through education, training and research.
Ergene O
Circ J; 2012; 76(4):774-7. PubMed ID: 22451444
[No Abstract] [Full Text] [Related]
20. Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative.
Warner JJ; Crook HL; Whelan KM; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; Hernandez AF; McClellan MB; Califf RM; Brown N;
Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006606. PubMed ID: 32683985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
